Dallas, TX 4/15/2008 5:07:08 AM
News / Finance

OTCPicks.com Stocks to Watch for Tuesday, April 15th EESO, AVAL, PNHL, PSTI

OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets.  In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.

 

Our Stocks to Watch tomorrow Enzyme Environmental Solutions Inc. (OTC: EESO), Avalon Capital Holdings Corporation (OTC: AVAL), Planet Nutrition Holdings Inc. (OTC: PNHL) and Pluristem Therapeutics Inc. (NASDAQ: PSTI).

 

For the complete newsletter please visit: http://www.otcpicks.com/stocks-to-watch/index.php

 

For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/

 

ENZYME ENVIRONMENTAL (OTC: EESO)

"Up 58.82% on Monday"

 

Detailed Quote: http://www.otcpicks.com/quotes/EESO.php

 

Enzyme Consultants Organization (ECO) is a U.S. based manufacturer of industrial and agricultural enzyme products. All manufacturing, testing, and formulating are conducted in its manufacturing plant, located in Fort Wayne, Indiana. ECO strives to become a leader in ecological friendly or “Green Products” targeting the industrial and agricultural markets. It is our goal to have the best performing products on the market in each industry. Developing a growing and satisfied customer base is our number one marketing strategy.

 

AVALON CAPITAL HOLDINGS (OTC: AVAL)

"Up 42.86% on Monday"

 

Detailed Quote: http://www.otcpicks.com/quotes/AVAL.php

 

Avalon Capital Holdings Corporation, through its subsidiaries, develops, markets, and distributes high-performance trading software to financial institutions that engage in online trading. The Company specializes in products and turnkey solutions related to the Foreign Exchange (”Forex”) market. For additional information, visit http://www.avaloncapitalholdings.com/ or e-mail info@avaloncapitalholdings.com.

 

PLANET NUTRITION HOLDINGS (OTC: PNHL)

"Up 50.00% on Monday"

 

Detailed Quote: http://www.otcpicks.com/quotes/PNHL.php

 

Planet Nutrition, Inc. has been in business since 1999 as a retailer of nutritional products and programs in the diet and nutrition industry. By offering a superior product line, employing innovative marketing techniques and developing strategic partnerships with manufacturers and distributors, the company maintains an uncompromising commitment to quality while ensuring the best value to our customers. Visit Planet Nutrition online at http://www.planetnutritiononline.com/.

 

PLURISTEM THERAPEUTICS (NASD: PSTI)

"Up 35.21% on Monday"

 

Detailed Quote: http://www.otcpicks.com/quotes/PSTI.php

 

Pluristem Therapeutics, Inc. engages in the research and development of the mesenchymal and stem cell production technology, and the commercialization of cell therapy products. The company is developing a platform designed to create a functional stem cell production system that can treat severe blood, cardiovascular, autoimmune, and other disorders. It develops PluriX Bioreactor System, which is designed to be a system of stromal cell cultures and substrates that creates an artificial physiological environment where mesenchymal stem cells can grow and reproduce outside of the human body without any use of exogenous biologics or pharmacologicals. The company's principal product, PLX-I is intended to resolve the shortfall of matched tissue for bone marrow transplantation by improving the engraftment of hematopoietic stem cells contained umbilical cord blood. Pluristem's products are derived from mesenchymal stem cells obtained from the placenta and expanded in its proprietary PluriX 3D bioreactor that imitates the natural microstructure of bone marrow and does not require supplemental growth factors, cytokines, or other exogenous materials. The company was founded in 2001 as A.I. Software, Inc. and changed its name to Pluristem Life Systems, Inc. in 2003. Further, it changed its name to Pluristem Therapeutics, Inc. in November 2007. Pluristem Therapeutics is based in Haifa, Israel.

 

About OTCPicks.com

 

OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor.  The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

 

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

 

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

 

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.